WO2026064643A1 - Composés, compositions et leurs procédés d'utilisation - Google Patents
Composés, compositions et leurs procédés d'utilisationInfo
- Publication number
- WO2026064643A1 WO2026064643A1 PCT/US2025/047207 US2025047207W WO2026064643A1 WO 2026064643 A1 WO2026064643 A1 WO 2026064643A1 US 2025047207 W US2025047207 W US 2025047207W WO 2026064643 A1 WO2026064643 A1 WO 2026064643A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkyl
- compound
- cycloalkyl
- aryl
- alkynyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des composés qui se lient à et/ou dégradent une ou plusieurs kinases dépendantes de la cycline, ainsi que des compositions pharmaceutiques comprenant les composés de l'invention, et des méthodes de traitement de maladies, de troubles et d'états médiés, au moins en partie, par des kinases dépendantes de la cycline.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202463697347P | 2024-09-20 | 2024-09-20 | |
| US63/697,347 | 2024-09-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2026064643A1 true WO2026064643A1 (fr) | 2026-03-26 |
Family
ID=99168791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2025/047207 Pending WO2026064643A1 (fr) | 2024-09-20 | 2025-09-19 | Composés, compositions et leurs procédés d'utilisation |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2026064643A1 (fr) |
-
2025
- 2025-09-19 WO PCT/US2025/047207 patent/WO2026064643A1/fr active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7675777B2 (ja) | 免疫調節剤としての複素環式化合物 | |
| US11760756B2 (en) | Crystalline form of a PD-1/PD-L1 inhibitor | |
| US11753406B2 (en) | Salts of a PD-1/PD-L1 inhibitor | |
| US20240132523A1 (en) | Salts and crystalline forms of a pd-1/pd-l1 inhibitor | |
| US10329255B2 (en) | Salts of an LSD1 inhibitor | |
| US20180057486A1 (en) | Heterocyclic compounds as immunomodulators | |
| JP2023533982A (ja) | Gas41阻害剤及びその使用方法 | |
| WO2026064643A1 (fr) | Composés, compositions et leurs procédés d'utilisation | |
| HK40097413A (en) | Heterocyclic compounds as immunomodulators | |
| HK40097413B (en) | Heterocyclic compounds as immunomodulators | |
| HK40047182B (en) | Heterocyclic compounds as immunomodulators | |
| HK40047182A (en) | Heterocyclic compounds as immunomodulators | |
| WO2023019430A1 (fr) | Composés à utiliser en tant qu'immunomodulateurs d'interactions pd-l1 | |
| HK40009864A (en) | Heterocyclic compounds as immunomodulators | |
| HK40009864B (en) | Heterocyclic compounds as immunomodulators | |
| HK40014224B (en) | Pyridine derivatives as immunomodulators | |
| HK40014224A (en) | Pyridine derivatives as immunomodulators |